2150 Low rates of hospitalizations with TAS-102 in the European (EU) subregion of the Phase 3 RECOURSE trial in patients (pts) with metastatic colorectal cancer (mCRC). (September 2015) - Falcone, A.; Garcia-Carbonero, R.; Tabernero, J.; Sobrero, A.; Peeters, M.; Zaniboni, A.; Hochster, H.; Lenz, H.J.; Tran, B.; Yamaguchi, K.; Muro, K.; Denda, T.; et al.